Your shopping cart is currently empty

Anakinra (Raleukin) is a cytokine inactivator and interleukin 1 receptor antagonist that can be used to study secondary phagocytic lymphohistiocytosis and rheumatoid arthritis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $105 | - | In Stock | |
| 5 mg | $262 | In Stock | In Stock | |
| 10 mg | $411 | In Stock | In Stock | |
| 25 mg | $822 | 7-10 days | 7-10 days | |
| 50 mg | $1,230 | - | In Stock | |
| 100 mg | $1,970 | 7-10 days | 7-10 days |
| Description | Anakinra (Raleukin) is a cytokine inactivator and interleukin 1 receptor antagonist that can be used to study secondary phagocytic lymphohistiocytosis and rheumatoid arthritis. |
| In vivo | Etanercept was administered intraperitoneally at a dose of 5 mg/kg, and Anakinra was administered intraperitoneally at a dose of 100 mg/kg once daily for 7 days. The combination of the two significantly improved the survival of borderline mass human islet grafts in immunodeficient mice. [2] Anakinra enhances tumor growth inhibition in mice treated with peptide vaccines and beta-(1-3),(1-6)-D-glucan. [3] |
| Synonyms | Raleukin, AMG-719, AMG719 |
| Cas No. | 143090-92-0 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.